Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy

Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy

Pancreatic adenocarcinoma (PDAC) remains a formidable disease that needs improved therapeutic strategies. Even though immunotherapy has revolutionized treatment for various solid tumor types, it remains largely ineffective in treating individuals with PDAC. This review describes how the application...

Full description

Bibliographic Details
Main Authors:	Jacob S. Bowers, Stefanie R. Bailey, Mark P. Rubinstein, Chrystal M. Paulos, E. Ramsay Camp
Format:	Article
Language:	English
Published:	PAGEPress Publications 2019-08-01
Series:	Oncology Reviews
Subjects:	Pancreatic adenocarcinoma immunology genomics immunotherapy neoantigen T cell
Online Access:	https://www.oncologyreviews.org/index.php/or/article/view/430

Similar Items

A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients
by: Michal Bassani-Sternberg, et al.
Published: (2019-08-01)

A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment
by: Zheling Chen, et al.
Published: (2021-08-01)

Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges
by: Ashleigh R. Poh, et al.
Published: (2021-06-01)

Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy
by: Frederick S. Varn, et al.
Published: (2018-06-01)

The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery of the tumor
by: Saber Amin, et al.
Published: (2020-09-01)

Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer
by: Andrew J. Gunderson, et al.
Published: (2021-01-01)

Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
by: Jia-qiao Fan, et al.
Published: (2020-02-01)

Exosomes and the Future of Immunotherapy in Pancreatic Cancer
by: Ines A. Batista, et al.
Published: (2019-01-01)

Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
by: He-Li Gao, et al.
Published: (2020-10-01)

Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
by: S. K. Daniel, et al.
Published: (2019-04-01)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
by: Ruiyu Li, et al.
Published: (2021-07-01)

Emerging Therapies and Future Directions in Targeting the Tumor Stroma and Immune System in the Treatment of Pancreatic Adenocarcinoma
by: Daniel H. Ahn, et al.
Published: (2018-06-01)

Immunotherapy on Pancreatic Cancer: Current Status and Future Perspectives
by: JIN Xin, et al.
Published: (2020-03-01)

Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
by: Zoe C. Schmiechen, et al.
Published: (2021-01-01)

The Association of the Sequence of Immunotherapy With the Survival of Unresectable Pancreatic Adenocarcinoma Patients: A Retrospective Analysis of the National Cancer Database
by: Saber Amin, et al.
Published: (2020-09-01)

Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer
by: Jiajia Zhang, et al.
Published: (2018-01-01)

Immunotherapy for pancreatic ductal adenocarcinoma: Challenges and opportunities
by: GE Weiyu, et al.
Published: (2019-05-01)

Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy
by: Daniel J. Verdon, et al.
Published: (2021-08-01)

Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy
by: Yicheng Zhu, et al.
Published: (2021-06-01)

The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis
by: Saber Amin, et al.
Published: (2020-06-01)

Omics Approaches in Pancreatic Adenocarcinoma
by: Iranzu González-Borja, et al.
Published: (2019-07-01)

Neoantigen vaccine: an emerging tumor immunotherapy
by: Miao Peng, et al.
Published: (2019-08-01)

Paraneoplastic Hyperleukocytosis in Pancreatic Adenocarcinoma
by: Evan S. Wu, et al.
Published: (2017-11-01)

The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications
by: Xiaomeng Liu, et al.
Published: (2019-12-01)

Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact
by: María Laura Gutiérrez, et al.
Published: (2021-09-01)

Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome?
by: Shelize Khakoo, et al.
Published: (2021-08-01)

Clinical predictors of resectability of pancreatic adenocarcinoma
by: Majid A Almadi, et al.
Published: (2013-01-01)

Targeting neoantigens for cancer immunotherapy
by: Xuan Zhao, et al.
Published: (2021-07-01)

Modularly Programmable Nanoparticle Vaccine Based on Polyethyleneimine for Personalized Cancer Immunotherapy
by: Jutaek Nam, et al.
Published: (2021-03-01)

Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma
by: Sahar Ghassem-Zadeh, et al.
Published: (2017-06-01)

A feasible CT feature to differentiate focal‐type autoimmune pancreatitis from pancreatic ductal adenocarcinoma
by: Chaobin He, et al.
Published: (2019-10-01)

Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspective
by: Wu-Hu Zhang, et al.
Published: (2020-01-01)

Identifying Potential Neoantigens for Cervical Cancer Immunotherapy Using Comprehensive Genomic Variation Profiling of Cervical Intraepithelial Neoplasia and Cervical Cancer
by: Chaohui Bao, et al.
Published: (2021-06-01)

Expression and prognostic impact of FZDs in pancreatic adenocarcinoma
by: Yang Li, et al.
Published: (2021-02-01)

A rare case of pancreatic adenocarcinoma metastasized to the bladder
by: James Frederick W. Pike, et al.
Published: (2020-11-01)

Apparent diffusion coefficient of pancreatic adenocarcinoma: is there any congruity with tumor resectability?
by: M. Abdel Kader, et al.
Published: (2019-09-01)

Clinical Outcome of Exocrine Pancreatic Adenocarcinoma: A Single Center Experience
by: Suzy Gohar, et al.
Published: (2017-12-01)

Utility of Exosomes in the Diagnosis and Treatment of Pancreatic Adenocarcinoma
by: Leo I. Amodu, et al.
Published: (2016-01-01)

Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma
by: John C. Chang, et al.
Published: (2017-03-01)

Syndecans and Pancreatic Ductal Adenocarcinoma
by: Nausika Betriu, et al.
Published: (2021-02-01)

Cannot write session to /tmp/vufind_sessions/sess_rk3lqmi2k2q57bf7ccqut794kh